Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries.
BackgroundLive oral rotavirus vaccines (LORVs) have significantly reduced rotavirus hospitalizations and deaths worldwide.However, LORVs are less effective in low- and middle-income countries (LMICs).Next-generation rotavirus vaccines (NGRVs) may be more effective but require administration by injection or a neonatal oral dose, adding operational c